Ostrum Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$384K Sell
4,245
-2,489
-37% -$228K 0.02% 366
2025
Q4
$606K Buy
6,734
+2,617
+64% +$248K 0.03% 360
2025
Q3
$406K Sell
4,117
-127
-3% -$12.6K 0.02% 432
2025
Q2
$387K Sell
4,244
-121
-3% -$11.7K 0.02% 437
2025
Q1
$494K Sell
4,365
-116
-3% -$12.4K 0.03% 414
2024
Q4
$473K Sell
4,481
-8,189
-65% -$879K 0.04% 411
2024
Q3
$1.37M Buy
12,670
+154
+1% +$16.8K 0.11% 265
2024
Q2
$1.36M Sell
12,516
-973
-7% -$115K 0.12% 258
2024
Q1
$1.78M Hold
13,489
0.14% 246
2023
Q4
$1.64M Buy
13,489
+3,926
+41% +$438K 0.14% 232
2023
Q3
$1.07M Buy
9,563
+1,935
+25% +$246K 0.1% 291
2023
Q2
$1.11M Buy
7,628
+7
+0.1% +$951 0.09% 296
2023
Q1
$985K Buy
+7,621
New +$957K 0.09% 314

Other funds holding ZBH

Ostrum Asset Management's ZBH Position: Q1 2026 in Review

Ostrum Asset Management reduced its Zimmer Biomet (ZBH) stake by 37% in Q1 2026, selling an estimated $228K and leaving 4,245 shares worth $384K. The position accounts for 0.02% of the portfolio, ranked #366.

Ostrum Asset Management first reported a position in ZBH in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.78M in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Ostrum Asset Management held 4,245 shares of Zimmer Biomet worth $384K as of Q1 2026.
  • Ostrum Asset Management sold 2,489 Zimmer Biomet shares in Q1 2026, an estimated $228K.
  • Zimmer Biomet made up 0.02% of Ostrum Asset Management's portfolio in Q1 2026, its #366 holding.
  • Ostrum Asset Management first reported a position in Zimmer Biomet in Q1 2023 and has held it in 13 quarters since.
  • Ostrum Asset Management's Zimmer Biomet position peaked at $1.78M in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.